Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School, joins Dean Henri Ford to give insight into this devastating illness and the search for better outcomes. https://med.miami.edu/podcast/inside-umiami-medicine
Listen to this podcast below: